Previous 10 | Next 10 |
Psychedelics, like psilocybin may be helpful in treating weight issues and obesity. In fact, NeonMind Biosciences’ (CSE:NEON) (OTC:NMDBF) “first drug candidate aims to use synthetic psilocybin to enhance a patient's ability to alter behaviours that cause weight loss throug...
COMPASS Pathways granted two US patents London, UK – 23 March 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today tha...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 22, 2021 – A pressing need for new treatment options for people suffering from mental health issues has opened the door to a new era of mental health innovation. Researchers,...
Numinus recently became the first Canadian public company to complete a legal harvest of Psilocybe mushrooms. The company plans to significantly expand its research facility and its revenues are growing fast thanks to the acquisition of clinics that use psychedelic therapy treatm...
Palm Beach, FL – March 19, 2021 – Psychedelic Medicines also called as hallucinogenics, are a group of substances including chemicals, such as LSD, and plants that are used in the treatment of various mental disorders such as resistant depression, panic disorder, stress and op...
Market participants are underestimating COMP360 probabilities of success in rNPV-models. There is 2-3x upside in the event of full FDA-approval in the U.S., factoring in potential future share dilution. Ancient and historical use of 5-HT2A agonists in the 1950s to 1970s and shared...
A new era of medicine may be on the rise thanks to growing interest in psychedelic drug development, according to one investment expert. Matt Carr, chief trends strategist at the Oxford Club, spoke to the Investing News Network (INN) about why he’s bullish on the pote...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Investors could be tested again if bonds are volatile and push yields higher to pressure growth stocks and tech favorite...
The IPO market starts to pick back up with eight IPOs scheduled to raise $2.2 billion in the week ahead. Street research is expected for one company on Sunday, 3/14. Lock-up periods will be expiring for 15 companies. For further details see: U.S. IPO Week Ahead: The Spri...
This is Psychedellux, the week’s top news in the psychedelic industry Psychedelic medicine company Compass Pathways plc (Nasdaq: CMPS) reported its financial results for the fourth quarter and year-end 2020 and gave an update on recent progress across its ...
News, Short Squeeze, Breakout and More Instantly...
2024-08-01 23:30:19 ET Image source: The Motley Fool. Compass Pathways Plc (NASDAQ: CMPS) Q2 2024 Earnings Call Aug 01, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Tr...
Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression expected in fourth quarter 2024 Gino Santini to join Board of Directors as Chairman Lori Englebert named new Chief Commercial Officer Cash position of $228.6 million ...
LONDON, July 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2024 ending June 30, 2024, a...